What is the appropriate evaluation and management for a 53-year-old man with normocytic/macrocytic anemia, low serum iron, low total iron‑binding capacity (TIBC), low transferrin, low iron saturation, elevated ferritin, elevated C‑reactive protein, normal vitamin B12 and folate, negative autoimmune and celiac serology, and normal liver and kidney function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Anemia of Chronic Disease with Functional Iron Deficiency

This patient has anemia of chronic disease (ACD) with functional iron deficiency, evidenced by elevated ferritin (415 ng/mL) with low iron saturation (15%) and elevated CRP (15 mg/L), and requires investigation for the underlying inflammatory source followed by treatment of both the inflammation and iron deficiency.

Diagnosis

The laboratory pattern is diagnostic for ACD with functional iron deficiency 1, 2, 3:

  • Ferritin >100 μg/L (415) + transferrin saturation <16-20% (15%) = ACD with functional iron deficiency
  • Elevated CRP (15 mg/L) confirms active inflammation
  • Low TIBC (231) and low transferrin (185) are characteristic of inflammation suppressing iron metabolism
  • Normal MCV (96) indicates this is normocytic anemia, not yet microcytic

The elevated ferritin is an acute-phase reactant masking true iron deficiency. In the presence of inflammation, ferritin up to 100 μg/L can still indicate iron deficiency, and when ferritin is between 30-100 μg/L with transferrin saturation <16-20%, a combination of true iron deficiency and ACD is likely 1, 2. However, this patient's ferritin of 415 with transferrin saturation of 15% meets criteria for ACD with functional iron deficiency 3.

Critical Next Steps

1. Identify the Inflammatory Source

The CRP of 15 mg/L indicates significant inflammation. With negative autoimmune markers (ANA, RF, celiac panel), focus on:

  • Gastrointestinal evaluation: Colonoscopy and upper endoscopy to evaluate for inflammatory bowel disease (IBD), malignancy, or occult bleeding 4, 5

    • IBD is a common cause of this exact pattern (anemia affects 66% of IBD inpatients) 1
    • In men over 50, bidirectional endoscopy is recommended to exclude GI malignancy 4, 5
  • Infectious workup: Consider chronic infections (HIV, hepatitis, tuberculosis)

  • Malignancy screening: Age-appropriate cancer screening, CT chest/abdomen/pelvis if clinically indicated

  • Chronic kidney disease: Already ruled out with normal kidney function

2. Iron Supplementation Strategy

Iron supplementation should be initiated now 1, 3:

  • Intravenous iron is preferred over oral iron in the setting of inflammation 3

    • Inflammation impairs oral iron absorption through hepcidin upregulation
    • IV iron bypasses this block and is more effective in ACD
  • Goal: Hemoglobin increase of ≥2 g/dL within 4 weeks 3

  • Monitoring: Recheck hemoglobin in 2-4 weeks 5

3. Treat the Underlying Inflammation

Once the source is identified, treating the underlying condition is the first step 1:

  • Anti-inflammatory therapy for IBD if diagnosed
  • Antibiotics for infection
  • Oncologic treatment for malignancy
  • However, treating inflammation alone rarely normalizes hemoglobin without iron supplementation 1

Common Pitfalls to Avoid

  1. Do not be falsely reassured by "normal" ferritin of 415: In inflammation, ferritin is an acute-phase reactant and can be elevated despite functional iron deficiency 1

  2. Do not give oral iron alone: With active inflammation (CRP 15), oral iron absorption is impaired and IV iron is more effective 3

  3. Do not delay GI evaluation: In a 53-year-old male with anemia and inflammation, GI pathology (including malignancy) must be excluded 4, 5

  4. Do not ignore the low TIBC: TIBC <250 μg/dL strongly suggests ACD rather than pure iron deficiency 6

Why This Pattern Matters

The combination of low iron, low TIBC, low transferrin, elevated ferritin, and elevated CRP creates a state where:

  • Hepcidin (upregulated by inflammation) blocks iron release from macrophages 3, 7
  • Iron is sequestered in storage but unavailable for erythropoiesis (functional iron deficiency)
  • Inflammatory cytokines suppress erythropoietin production and bone marrow response 7

This explains why the hemoglobin is 10.6 g/dL despite ferritin of 415—the iron is trapped and cannot be used for red cell production 1, 3.

Related Questions

In a patient with macrocytic anemia, low hemoglobin, low red blood cell count, low serum iron, high ferritin, low total iron‑binding capacity, and elevated mean corpuscular volume, what is the most likely diagnosis and what is the appropriate management?
What is the appropriate management for a patient with ferritin 10.6 ng/mL, total iron‑binding capacity 460 µg/dL, transferrin saturation 13 %, erythrocyte sedimentation rate 22 mm/hr, and mean corpuscular volume 82 fL?
In a 49-year-old woman with low transferrin (181 mg/dL), low total iron‑binding capacity (226 µg/dL), and elevated ferritin (264 ng/mL), what is the most likely diagnosis and what are the appropriate next steps in management?
In a patient presenting to the emergency department with fever, cough, leukocytosis with neutrophilia, microcytic anemia (hemoglobin 9 g/dL, mean corpuscular volume 65 fL), low serum iron, high ferritin, and elevated total iron‑binding capacity, what is the most likely type of anemia?
Can you explain how to review and document the results of each individual laboratory or imaging test for a patient being managed for iron‑deficiency anemia and vitamin B12 deficiency?
What risks does a corrected QT interval (QTcB) of 513 ms and a serum potassium of 5.4 mmol/L pose in a patient with type 1 diabetes mellitus?
What is the significance of a low total thyroxine (T4) level and how should it be evaluated and managed?
How does Vraylar (cariprazine) work in bipolar disorder?
What is the appropriate workup for a possible gastric ulcer in primary care?
In a 21-year-old male with mildly elevated total bilirubin (predominantly indirect), markedly increased serum iron, ferritin, and transferrin saturation, and normal hemoglobin and hematocrit, what is the differential diagnosis and what are the appropriate next steps?
Can cariprazine (Vraylar) be co-administered with lurasidone (Latuda) or should it replace lurasidone?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.